A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Status:
Recruiting
Trial end date:
2024-10-15
Target enrollment:
Participant gender:
Summary
The objective of the trial is to evaluate the safety and efficacy of SM-020 gel 1.0% in
subjects with Seborrheic Keratosis (SK) compared to vehicle gel. It is a randomized,
double-blind, vehicle-controlled trial. Approximately 60 subjects will be enrolled. Subjects
will apply their assigned investigational product twice daily for 4 consecutive weeks.
Subjects will be followed for 12-weeks post final application for a total of approximately
16-weeks of required participation in the study.